DR. WALTER GREGORY SHAKESPEARE, D.O.
Osteopathic Medicine at Broad St, Philadelphia, PA

License number
Pennsylvania OT013798
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address 2
230 NORTH Broad St, Philadelphia, PA 18062
4769 Meadowview Dr, Macungie, PA 18062
Phone
(610) 390-7668

Personal information

See more information about WALTER GREGORY SHAKESPEARE at radaris.com
Name
Address
Phone
Walter Shakespeare, age 72
4769 Meadowview Dr, Macungie, PA 18062
(610) 390-0416
Walter J Shakespeare, age 73
4769 Meadowview Dr, Macungie, PA 18062
(610) 391-0269
(610) 391-1523
(610) 530-3161
Walter S Shakespeare
2741 Rolling Green Dr, Macungie, PA 18062
(610) 965-2821

Professional information

See more information about WALTER GREGORY SHAKESPEARE at trustoria.com
Walter G Shakespeare Photo 1
Dr. Walter G Shakespeare, Philadelphia PA - DO (Doctor of Osteopathic Medicine)

Dr. Walter G Shakespeare, Philadelphia PA - DO (Doctor of Osteopathic Medicine)

Specialties:
Internal Medicine
Address:
230 N Broad St, Philadelphia 19102
(610) 390-7668 (Phone)
DREXEL INTERNAL MEDICINE HUH
1427 Vine St SUITE 6, Philadelphia 19102
(215) 762-4400 (Phone)
Languages:
English
Hospitals:
230 N Broad St, Philadelphia 19102
DREXEL INTERNAL MEDICINE HUH
1427 Vine St SUITE 6, Philadelphia 19102
Hahnemann University Hospital
230 North Broad St, Philadelphia 19102


Walter Shakespeare Photo 2
Flowometry In Optical Coherence Tomography For Analyte Level Estimation

Flowometry In Optical Coherence Tomography For Analyte Level Estimation

US Patent:
2014005, Feb 20, 2014
Filed:
Oct 25, 2013
Appl. No.:
14/063977
Inventors:
Walter J. Shakespeare - Macungie PA, US
George Kechter - Peoria IL, US
Phillip William Wallace - Bernardsville NJ, US
Matthew J. Schurman - Somerset NJ, US
Assignee:
GLT ACQUISITION CORP. - Irvine CA
International Classification:
A61B 5/1455, A61B 5/145, A61B 5/00, A61B 5/026
US Classification:
600316, 600425
Abstract:
Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.


Walter Shakespeare Photo 3
System And Method For Creating A Stable Optical Interface

System And Method For Creating A Stable Optical Interface

US Patent:
8219172, Jul 10, 2012
Filed:
Mar 17, 2006
Appl. No.:
11/378538
Inventors:
Matthew J. Schurman - Somerset PA, US
Phillip William Wallace - Bernardsville NJ, US
Walter J. Shakespeare - Macungie PA, US
Howard P. Apple - Winter Park FL, US
William Henry Bennett - Bethlehem PA, US
Assignee:
GLT Acquisition Corp. - Irvine CA
International Classification:
A61B 5/1455
US Classification:
600344, 600310, 600316
Abstract:
A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor.


Walter Shakespeare Photo 4
Apparatus And Method For Creating A Stable Optical Interface

Apparatus And Method For Creating A Stable Optical Interface

US Patent:
2012027, Nov 1, 2012
Filed:
Jul 9, 2012
Appl. No.:
13/544788
Inventors:
Matthew J. Schurman - Somerset NJ, US
Phillip William Wallace - Bernardsville NJ, US
Walter J. Shakespeare - Macungie PA, US
Howard P. Apple - Winter Park FL, US
William Henry Bennett - Bethlehem PA, US
Assignee:
GLT ACQUISITION CORP. - Irvine CA
International Classification:
A61B 5/1455
US Classification:
600316
Abstract:
A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor.


Walter Shakespeare Photo 5
Method And Apparatus For Monitoring Blood Constituent Levels In Biological Tissue

Method And Apparatus For Monitoring Blood Constituent Levels In Biological Tissue

US Patent:
8204566, Jun 19, 2012
Filed:
Aug 2, 2007
Appl. No.:
11/832721
Inventors:
Matthew J. Schurman - Somerset PA, US
Walter J. Shakespeare - Macungie PA, US
Assignee:
GLT Acquisition Corp. - Irvine CA
International Classification:
A61B 5/1455
US Classification:
600322, 600310, 600316
Abstract:
In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.


Walter Shakespeare Photo 6
Monitoring Blood Constituent Levels In Biological Tissue

Monitoring Blood Constituent Levels In Biological Tissue

US Patent:
2012020, Aug 16, 2012
Filed:
Apr 25, 2012
Appl. No.:
13/456137
Inventors:
Matthew J. Schurman - Somerset NJ, US
Walter J. Shakespeare - Macungie PA, US
Assignee:
GLT ACQUISITION CORP. - Irvine CA
International Classification:
A61B 5/1455
US Classification:
600316, 600322
Abstract:
In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.


Walter Shakespeare Photo 7
Fixture With At Least One Trough And Method Of Using The Fixture In A Plasma Or Ion Beam

Fixture With At Least One Trough And Method Of Using The Fixture In A Plasma Or Ion Beam

US Patent:
6210546, Apr 3, 2001
Filed:
Oct 29, 1998
Appl. No.:
9/182722
Inventors:
David G. Coult - Oley PA
Gustav E. Derkits - New Providence NJ
Walter J. Shakespeare - Macungie PA
Duane D. Wendling - Kutztown PA
Frederick A. Yeagle - Leesport PA
Assignee:
Lucent Technologies Inc. - Murray Hill NJ
International Classification:
C23C 1446, C23C 1450, C23F 100
US Classification:
20419232
Abstract:
Optical components, such as optical semi-isolators, are placed in a fixture that exposes at least a portion of the mounting surface of each optical component when a plasma or ion beam is directed at one side of the fixture, while shielding sensitive surfaces of the optical components (e. g. , an optical element mounted within the frame of the optical component) from direct exposure to the plasma or ion beam. Exposure to the plasma or ion beam removes contaminants (e. g. , metal oxide) that form on the mounting surface during the fabrication of the optical components when the optical element is mounted within its frame using glass solder in a heated oxygenated environment (e. g. , air). By removing enough of the contaminants, the plasma or ion beam cleaning step produces optical components that can be reliably mounted onto substrates, such as the ceramic substrates used in encapsulated laser packages, using flux-less auto-bonding techniques.


Walter Shakespeare Photo 8
Method For Data Reduction And Calibration Of An Oct-Based Physiological Monitor

Method For Data Reduction And Calibration Of An Oct-Based Physiological Monitor

US Patent:
8306596, Nov 6, 2012
Filed:
Sep 22, 2010
Appl. No.:
12/888318
Inventors:
Matthew J. Schurman - Somerset NJ, US
Walter J. Shakespeare - Macungie PA, US
William Henry Bennett - Bethlehem PA, US
Assignee:
GLT Acquisition Corp. - Irvine CA
International Classification:
A61B 5/1455
US Classification:
600322, 600316
Abstract:
The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method.


Walter Shakespeare Photo 9
Method For Data Reduction And Calibration Of An Oct-Based Physiological Monitor

Method For Data Reduction And Calibration Of An Oct-Based Physiological Monitor

US Patent:
2013006, Mar 7, 2013
Filed:
Nov 2, 2012
Appl. No.:
13/668013
Inventors:
Walter J. Shakespeare - Macungie PA, US
William Henry Bennett - Bethlehem PA, US
Assignee:
GLT ACQUISITION CORP. - Irvine CA
International Classification:
A61B 6/02, A61B 5/1455
US Classification:
600316, 600428
Abstract:
The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method.


Walter Shakespeare Photo 10
Back-Up Power System

Back-Up Power System

US Patent:
8049364, Nov 1, 2011
Filed:
Jun 4, 2008
Appl. No.:
12/133048
Inventors:
Walter Jeffrey Shakespeare - Macungie PA, US
Clarence William Crompton - Macungie PA, US
Assignee:
Electrikus, Inc. - Bethlehem PA
International Classification:
H02J 9/00
US Classification:
307 64
Abstract:
A substantially uninterruptible backup power system to provide power to common household appliances comprises a rechargeable battery, a trickle-charging circuit to keep the battery fully charged at all times from the receptacle power, a DC to AC inverter to supply standard AC line voltage from the battery to the lamp, a relay switch, controlled by main power voltage, to switch to the backup system when main power fails, and a timing circuit to optimize a voltage output of the system based on current battery voltage and a desired time period for the voltage output. The system can be set to operate only when the appliance is turned on, which optimizes the current and power required to provide backup power to the appliance for a maximum period of time.